Beruflich Dokumente
Kultur Dokumente
1.
THE FIRST WAVE OF BLOCKCHAIN HEALTH PROJECTS ARE
CENTRALLY MANAGED AND DON’T PROVIDE OWNERSHIP
STAKES TO WOULD BE CONTRIBUTORS.
2.
WE GIVE ANYONE WHO WANTS TO BUILD OR IMPROVE A
HEALTH DATA COMMONS THE MEANS TO DO SO, ALONG
WITH THE OPPORTUNITY TO BE AN OWNER.
WE PROVIDE HIGH-POWERED TOOLS ALONG WITH OWNERSHIP
MANY CANCER PATIENTS ARE WILLING TO DONATE THEIR DATA FOR OUTCOMES
RESEARCH BUT FEW IF ANY WILL COLLECT/ORGANIZE THIS DATA.
2.
PEOPLE WHO CAN OPERATE ACROSS BLOCKCHAIN AND ML/AI ARE
INCREDIBLY SCARCE (AND EXPENSIVE)..
OF THESE, FAR LESS THAN 5% HAVE THE COMPLEX MATHS AND STATISTICS
TO RUN TRADITIONAL AI/ML.
3.
THE RESOURCES REQUIRED EXCLUDE ALL BUT PROFESSIONALS.
INDIVIDUALS CAN CREATE SECURE IDENTITIES AND POINT TO THEIR HEALTH DATA WITH
SOCIAL MEDIA-TYPE TAGGING SKILLS (@/#).
IN THE NEAR FUTURE, WE WILL OPTIMIZE OUR PARSING AND META-DATA EXTRACTION
PLUG-INS TO AUTOMATE THIS TASK.
EMPLOYING OUR ONTOLOGY DESIGN INTERFACE AND UNITY GAME ENGINE PLUG-INS,
YUMATCH ALLOWS PEOPLE WITH GRADE-SCHOOL EDUCATION TO TAG PEOPLE’S HEALTH DATA.
From here, it’s only a small step up to tag data relationships using our tool sets.
2.
WE OPEN AI/ML TO NEW CLASSES OF CITIZEN DATA SCIENTISTS
IN PHASE ONE, WE MAKE IT POSSIBLE FOR SCIENCE PHDS IN NON AI/ML DISCIPLINES TO BUILD
MODELS OF INTEREST TO THEM.
WE ARE ALSO EXPLORING HOW TO SONIFY AND VISUALIZE HEALTH DATA SO THAT MUSICIANS
AND ARTISTS CAN IDENTIFY AND INTERPRET COMPLEX PATTERNS, OTHERWISE LOST IN
TWO DIMENSIONS.
3.
AND DRAMATICALLY INCREASE THE RESOURCES AVAILABLE TO THEM
WE HAVE INCORPORATED OPTIMIZATION PROGRAMS THAT CAN IDENTIFY THE MOST EFFICIENT
SOFTWARE/HARDWARE RESOURCES FOR RUNNING MODELS, NOTABLY THE NVIDIA JETSON TX2
EMBEDDED AI SUPERCOMPUTER AND THE ROW ANALYTICS RACE ENGINE.
OUR VISION IS COMPREHENSIVE/
1. COMMON DID IDENTIFIER LINKS TO CONTENT ADDRESSABLE NAMESPACE, & SCHEMA DNS.
4. DATA STRUCTURING TOOLS: CROSS PLATFORM COMMON LANGUAGE RUNTIME COMPILER FOR
UNITY, ARDUINO, AND A VARIETY OF CYBERPHYSICAL SYSTEMS FOR COMMAND AND CONTROL
DYNAMICS
10. CUSTOM LINUX OPERATING SYSTEM OFFERS DOMAIN SPECIFIC MODELING, DISTRIBUTED
COLLABORATIVE COMPUTATION, ACROSS A CUSTOMIZABLE ECOSYSTEM OF APPLICATIONS
AND NETWORKING PROTOCOLS, AS WELL AS OVER 25 BLOCKCHAIN LIGHT WALLETS.
WE SUCCEED BY FOSTERING THE SUCCESS OF OTHERS
- DATA TRANSACTIONS
YUMATCH’S BUSINESS:
* ROCHE ACQUIRED FLATIRON/FOUNDATION MEDICINE FOR >$5B. THE REFERENCED CLINICO-GENOMIC DATABASE WAS A KEY ASSET OF BOTH COMPANIES
WE’VE BUILT A SOLID BASE TO GROW FROM
Fund expansion of 1.0 launch support emergence of Fund 1.0 launch and broaden
multiple health data co-ops, network with companies
also through collaboration generating health data.
with co’s that generate Foster dedicated knowledge
health data entrepreneur community.
*Grant solicitation will go longer and seed financing will start sooner
FOUNDERS AND TEAM CONCEPT
Jonny is a cyberneticist who builds bridges across human / computer systems in bioinformatics,
AI, complex adaptive systems, genomics, IOT and blockchain technologies.
He co-founded Sense Collective, an innovation/design studio and consultancy dedicated to
helping organizations unlock the Internet of Value. Dubowsky began mining bitcoin in 2013
and participated in the Ethereum ICO, as part of his larger research into distributed systems.
He has contributed to the open source development and community building efforts of several
different blockchain projects including Nexus Earth, Synereo (Pre-RChain), Cardstack, Factom,
and DASH. A life-long generative artist and musician, he has shared the stage with Meatloaf,
Everclear, Stevie Wonder, Debbie Harry, and many other artists.
Dubowsky’s guest lecture series at NYU ITP on Blockchain for Creative Coders is an ongoing JONNY DUBOWSKY
source of inspiration for connecting blockchain to the state of the art in VR/AR, Game Design,
3D Fabrication, and Human-Computer Interaction Design.
Ivan started Plexcera with only a publicly available DNA sequence and an animal model.
Within two years, the company had made a complex biological product for treating a ultra rare
disease that caused life-threatening arthritis in children. Ivan led the company through
successful meetings with the FDA and EMA and a partnership with the NIH. In 2016, he sold the
company’s key product to Roivant Sciences, a public biotech company, which formed an new
company around it.
Previously, Ivan was an executive at the Icahn School of Medicine at Mount Sinai, where he
helped Ross Cagan get the Center for Personalized Cancer Therapeutics started. He received
his scientific training at Sanofi, the French drug company, where he worked for thirteen years
IVAN GLANIN
To get great people, we are staffing YuMatch as a co-op, with stakes commensurate to contribution.
Others will join to build out specific channels via token curated registry mechanisms.
�
Leandra Tejedor, for example, is leading data sonification and education. She is co-founder of
Vidcode and Forbes 30 under 30 class of 2017. Similarly great people in AI, AR/VR, gaming and
blockchain disciplines, among others, are coming to us from great places like Yale and NYU.
Application Contact: Jonny Dubowsky Jonny@yumatch.app 917-699-3991 www.yumatch.app